LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.

Complete Analytical Workflows for GLP-1 Receptor Agonists

Brožury a specifikace | 2025 | Agilent TechnologiesInstrumentace
2D-LC, GPC/SEC, HPLC, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Software, LC/QQQ, Spotřební materiál, LC kolony
Zaměření
Farmaceutická analýza
Výrobce
Agilent Technologies
PDF verze ke stažení a čtení
 

Podobná PDF

Toggle
Workflow Solutions for Peptide Therapeutics - Application Compendium
Workflow Solutions for Peptide Therapeutics Application Compendium Table of Contents Introduction4 An emerging class of peptide therapeutics: GLP-15 Analytical advances in peptide therapeutics5 Key analyses for synthetic and recombinant peptide therapeutics 6 Types of impurities in peptide therapeutics 7 Agilent…
Klíčová slova
peptide, peptidereturn, returncontents, contentsadvancebio, advancebiotable, tableliraglutide, liraglutideagilent, agilentanalysis, analysisinfinitylab, infinitylabimpurities, impuritiessemaglutide, semaglutidesynthetic, syntheticmsd, msdnotes, notestherapeutics
Characterization of Forced Degradation Impurities of Glucagon-Like Peptide-1 Agonists by LC/Q-TOF Mass Spectrometry
Application Note Pharma & Biopharma Characterization of Forced Degradation Impurities of Glucagon‑Like Peptide-1 Agonists by LC/Q-TOF Mass Spectrometry Author Suresh Babu C.V. Agilent Technologies, Inc. Abstract Peptide biotherapeutics have gained increased attention due to their many therapeutic uses. This application…
Klíčová slova
oxidation, oxidationcounts, countsmono, monoamu, amudeconvoluted, deconvolutedmass, masscharge, chargetirzepatide, tirzepatidetri, triliraglutide, liraglutidenative, nativesemaglutide, semaglutideacquisition, acquisitionforced, forcedoxidized
Characterization and Quantification of Glucagon Like Peptide-1 Agonists and their Impurities Using Liquid Chromatography/Mass Spectrometry (LC/MS)
Poster Reprint ASMS 2025 Poster number TP 625 Characterization and Quantification of Glucagon Like Peptide-1 Agonists and their Impurities Using Liquid Chromatography/Mass Spectrometry (LC/MS) David L. Wong1 , Suresh Babu C.V.2 1Agilent Technologies, Inc., Santa Clara, CA, USA 2Agilent Technologies,…
Klíčová slova
oxidation, oxidationcounts, countsmono, monotirzepatide, tirzepatidenative, nativetri, trioxidized, oxidizedacquisition, acquisitioncharge, chargemass, massliraglutide, liraglutideorders, ordersmagnitude, magnitudedeconvoluted, deconvolutedunmodified
Impurity Profiling of GLP-1 Receptor Agonists by HILIC-MS
Application Note Pharma Impurity Profiling of GLP-1 Receptor Agonists by HILIC-MS Using an Agilent 1290 Infinity III Bio LC System and Agilent InfinityLab LC/MSD iQ Authors Abstract Piotr Alvarez, Cindy Lecluyse, Griet Debyser, Pat Sandra, and Koen Sandra RIC group…
Klíčová slova
exenatide, exenatidecharge, chargetirzepatide, tirzepatideabundance, abundancesemaglutide, semaglutiderelative, relativeresponse, responsehilic, hilicaib, aibmass, massimpurities, impuritiesmau, mauretention, retentionpeptide, peptidemin
Další projekty
GCMS
ICPMS
Sledujte nás
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.